All posts tagged "biotechnology news"

  • The Dish’s Weekly Biotechnology News Wrap Up – September 22, 2017

    This week’s headlines include: Bill and Melinda Gates Grade the World’s Health, How poliovirus unleashes an attack on glioblastoma, FDA Grants Orphan Drug Status to Amylyx’s AMX0035 for Treatment of ALS, Pain Therapeutics Wins Grants to Develop...

    • Posted September 22, 2017
    • 0
  • The Dish’s Weekly Biotechnology News Wrap Up – September 15, 2017

    This week’s headlines include: Impressed FDA panel unanimously recommends GSK shingles vaccine, FDA to Close Loophole Allowing Companies to Skirt Pediatric Study Requirements, Ventria Bioscience Plans to Double Biomanufacturing Capacity, California Assembly passes drug price transparency bill,...

    • Posted September 15, 2017
    • 0
  • The Dish’s Weekly Biotechnology News Wrap Up – September 8, 2017

    This week’s headlines include: FDA lays out new manufacturing inspection blueprint, Bayer, J&J in frame for bigger anti-clotting market opportunity, Diabetes drug results positive, Ligand says, Industry groups sue over Nevada drug price transparency law, Novartis Calls...

    • Posted September 8, 2017
    • 0
  • The Dish’s Weekly Biotechnology News Wrap Up – September 1, 2017

    This week’s headlines include: F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000, Samsung, Biogen version of AbbVie’s Humira approved in Europe, Gilead to Buy Kite, Maker of Cancer Treatments, for $11.9 Billion, MilliporeSigma to Acquire Natrix Separations, ‘Hit-and-run’...

    • Posted September 1, 2017
    • 0
  • The Dish’s Weekly Biotechnology News Wrap Up – August 25, 2017

    This week’s headlines include: Novartis Speeds New Anti-Malarial as Older Drug Loses Potency, Zika has all but disappeared in the Americas. Why?, Cellectis Starts BPDCN Phase I Trial with Gene-Edited CAR-T Therapy, FDA Offers Draft Guidance to...

    • Posted August 25, 2017
    • 0